Abstract:Context: Polyamidoamine (PAMAM) dendrimers have attracted lots of interest as drug carriers. And little study about whether pluronic-attached PAMAM dendrimers could be potential drug delivery systems has been carried on. Objective: Pluronic F127 (PF127) attached PAMAM dendrimers were designed as novel drug carriers. Methods: Two conjugation ratios of PF127-attached PAMAM dendrimers were synthesized. H-1 nuclear magnetic resonance (H-1-NMR), Fourier transform infrared spectrum (FTIR), element analysis and ninhydrin assay were used to characterize the conjugates. Size, zeta potential and critical micelle concentrations (CMC) were also detected. And DOX was incorporated into the hydrophobic interior of the conjugates. Studies on their drug loading and drug release were carried on. Furthermore, hemolysis and cytotoxicity assay were used to evaluate the toxicity of the conjugates. Results and discussion: PF127 was successfully conjugated to the fifth generation PAMAM dendrimer at two molar ratios of 19% and 57% (PF127 to surface amine per PAMAM dendrimer molecular). The conjugates showed an increased size and a reduced zeta potential. And higher CMC values were obtained than pure PF127. Compared with unconjugated PAMAM dendrimer, PF127 conjugation significantly reduced the hemolytic toxicity and cytotoxicity of PAMAM dendrimer in vitro. The encapsulation results showed that the ability to encapsulate DOX by the conjugate of 19% conjugation ratio was better than that of 57% conjugation ratio. And the maximum is similar to 12.87 DOX molecules per conjugate molecule. Moreover, the complexes showed a sustained release behavior compared to pure DOX. Conclusion: Findings from the in vitro study show that the PF127-attached PAMAM dendrimers may be potential carriers for drug delivery.

Preparation and in Vitro Release of Methotrexate Complexation with PEGylated Dendrimers

Enhanced Percutaneous Delivery of Methotrexate Using Micelles Prepared with Novel Cationic Amphipathic Material

PEGylated PAMAM Dendrimers As a Potential Drug Delivery Carrier:In Vitroandin Vivocomparative Evaluation of Covalently Conjugated Drug and Noncovalent Drug Inclusion Complex

PEGylated polyamidoamine dendrimer/methotrexate complex: pharmacokinetics and anti-tumor activity in normal and tumor-bearing rodents

Synthesis of PEGylated PAMAM Dendrimer As a Drug Carrier

Preparation and in vitro characterization of pluronic-attached polyamidoamine dendrimers for drug delivery.

Methotrexate-loaded biodegradable polymeric micelles: preparation, physicochemical properties and in vitro drug release.

Preparation and Antitumor Activity of a Polymeric Derivative of Methotrexate

In Situ Preparation of a Laminated Hydroxyapatite/ Methotrexate Complex

Self-aggregated nanoparticles from methoxy poly(ethylene glycol)-modified chitosan: synthesis; characterization; aggregation and methotrexate release in vitro.

Preparation and Characterization of PEGylated Poly-L-Lysine-Hydroxycamptothecin Nanoparticles Without and with Methotrexate

Synthesis and in vitro evaluation of methotrexate conjugated O,N-carboxymethyl chitosan via peptidyl spacers

Polyamidoamine dendrimer conjugated chitosan nanoparticles for the delivery of methotrexate.

Effects of PEG Surface Density and Chain Length on the Pharmacokinetics and Biodistribution of Methotrexate-Loaded Chitosan Nanoparticles.

Formation of methotrexate-PLLA-PEG-PLLA composite microspheres by microencapsulation through a process of suspension-enhanced dispersion by supercritical CO2.

Poloxamer 407 based-nanoparticles for controlled release of methotrexate

PEGylated PAMAM Dendrimer-Doxorubicin Conjugates: In Vitro Evaluation and In Vivo Tumor Accumulation

The Effect of Ph on the Polymer Degradation and Drug Release from PLGA‐mPEG Microparticles

Water-soluble poly(ethylene glycol) prodrug of pemetrexed: Synthesis, characterization, and preliminary cytotoxicity

In situ grafting of PEG Acrylate on drugs with aliphatic hydroxyl functionalities via RAFT polymerization to synthesize drug/polymer conjugates with improved water solubility

Kappa-carrageenan and sodium alginate-based pH-responsive hydrogels for controlled release of methotrexate